REVIEW PAPER
Computed tomography imaging of ovarian peritoneal carcinomatosis: a pictorial review
Submission date: 2018-06-13
Final revision date: 2018-06-24
Acceptance date: 2018-07-24
Publication date: 2018-12-04
Pol J Radiol, 2018; 83: 500-509
KEYWORDS
TOPICS
ABSTRACT
Gynaecological malignancies are the most common malignancies in women and also an important public health issue. In developing countries, there is a paucity of screening facilities and cancer awareness, so patients present at an advanced stage of disease, which severely limits the prognosis and clinical outcome. Among the gynaecological malignancies, ovarian malignancy has the second highest incidence in women according to the incidences. Ovarian malignancy is usually diagnosed at the advanced stages, and to improve the patient’s survival, debulking surgery is very important. Advanced-stage disease is treated with either debulking surgery followed by adjuvant chemotherapy or initial neoadjuvant chemotherapy followed by debulking surgery. Imaging is very important in patient selection, in determining who will benefit from neoadjuvant chemotherapy just before debulking surgery. This article highlights the role of computed tomography (CT) in the detection of patterns of spread of ovarian malignancy, important for staging and management.
REFERENCES (38)
1.
Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol 2009; 472: 413-437.
2.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
3.
Prat J; FIGO Committee on Gynecologic Oncology. FIGO Guidelines. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014; 124: 1-5.
4.
Javadi S, Ganeshan DM, Qayyum A, et al. Ovarian cancer, the revised FIGO staging system, and the role of imaging. AJR Am J Roentgenol 2016; 206: 1351-1360.
5.
Vergote I, Tropé CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010; 363: 943-953.
6.
National Institutes of Health. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Statistical summaries: cancer stat fact sheets (ovary) and cancer statistics review (CSR), 1975-2013. Available at: http:// seer.cancer.gov/statistics/summaries.html (Accessed: 27.04.2016).
7.
Tavassoli FA, Devilee P (eds.). Pathology and genetics of tumours of the breast and female genital organs. International Agency for Research on Cancer, Lyon 2003.
8.
Cannistra SA. Cancer of the ovary. N Engl J Med 2004; 351: 2519-2529. Review. Erratum in: N Engl J Med 2005; 352: 104.
9.
Zhang M, Cheung MK, Shin JY, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary – an analysis of 376 women. Gynecol Oncol 2007; 104: 396-400.
10.
Doubeni CA, Doubeni AR, Myers AE. Diagnosis and management of ovarian cancer. Am Fam Physician 2016; 93: 937-944.
11.
Pannu HK, Bristow RE, Montz FJ, et al. Multidetector CT of peritoneal carcinomatosis from ovarian cancer. RadioGraphics 2003; 23: 687-701.
12.
Coakley FV, Hricak H. Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 1999; 54: 563-574.
13.
Feldman GB, Knapp RC. Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. Am J Obstet Gynecol 1974; 119: 991-994.
14.
Rose PG, Piver MS, Tsukada Y, Lau TS. Metastatic patterns in histologic variants of ovarian cancer: an autopsy study. Cancer 1989; 64: 1508-1513.
15.
Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95: S161-S192.
16.
Akin O, Sala E, Moskowitz CS, et al. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology 2008; 248: 511-517.
17.
Nougaret S, Addley HC, Colombo PE, et al. Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 2012; 32: 1775-1800.
19.
Sugarbaker PH. Surgical responsibilities in the management of peritoneal carcinomatosis. J Surg Oncol 2010; 101: 713-724.
20.
Colombo PE, Mourregot A, Fabbro M, et al. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients. Eur J Surg Oncol 2009; 35: 135-143.
21.
Dvoretsky PM, Richards KA, Angel C, et al. Survival time, causes of death, and tumor/ treatment-related morbidity in 100 women with ovarian cancer. Hum Pathol 1988; 19: 1273-1279.
22.
Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988; 19: 57-63.
23.
Forstner R, Sala E, Kinkel K, Spencer JA. ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol 2010; 20: 2773-2780.
24.
Akhan O, Pringot J. Imaging of abdominal tuberculosis. Eur Radiol 2002; 12: 312-323.
25.
Horger M, Müller-Schimpfle M, Yirkin I, et al. Extensive peritoneal and omental lymphomatosis with raised CA 125 mimicking carcinomatosis: CT and intraoperative findings. Br J Radiol 2004; 77: 71-73.
26.
Levy AD, Arnáiz J, Shaw JC, et al. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics 2008; 28: 583-607.
27.
Bevan KE, Mohamed F, Moran BJ. Pseudomyxoma peritonei. World J Gastrointest Oncol 2010; 2: 44-50.
28.
Oei TN, Jagannathan JP, Ramaiya N, et al. Peritoneal sarcomatosis versus peritoneal carcinomatosis: imaging findings at MDCT. AJR Am J Roentgenol 2010; 195: W229-235.
29.
Pickhardt PJ, Fisher AJ, Balfe DM, et al. Desmoplastic small round cell tumor of the abdomen: radiologic-histopathologic correlation. Radiology 1999; 210: 633-638.
30.
Ake AC, Menzli A, Lecomte JC, et al. Peritoneal splenosis mimicking peritoneal carcinomatosis: a case report. Diagn Interv Imaging 2012; 93: 890-893.
31.
Chang ES, Bachul P, Szura M, et al. Peritoneal “melanosis”. Pol J Pathol 2015; 66: 330-333.
32.
Machado NO. Sclerosing encapsulating peritonitis: review. Sultan Qaboos Univ Med J 2016; 16: e142-151.
33.
Kamaya A, Federle MP, Desser TS. Imaging manifestations of abdominal fat necrosis and its mimics. Radiographics 2011; 31: 2021-2034.
34.
Tempany CM, Zou KH, Silverman SG, et al. Staging of advanced ovarian cancer: comparison of imaging modalities – report from the Radiological Diagnostic Oncology Group. Radiology 2000; 215: 761-767.
35.
Low RN, Barone RM, Lucero J. Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 2015; 22: 1708-1715.
36.
Bozkurt M, Doganay S, Kantarci M, et al. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different β values. Eur J Radiol 2011; 80: 224-228.
37.
Michielsen K, Vergote I, Op de Beeck K, et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 2014; 24: 889-901.
38.
An H, Lee EYP, Chiu K, Chang C. The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis. Clin Radiol 2018; 73: 597-609.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
